0001209191-17-018752.txt : 20170307
0001209191-17-018752.hdr.sgml : 20170307
20170307163710
ACCESSION NUMBER: 0001209191-17-018752
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170303
FILED AS OF DATE: 20170307
DATE AS OF CHANGE: 20170307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAPLAN GILLA
CENTRAL INDEX KEY: 0001247024
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 17672443
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
FORMER NAME:
FORMER CONFORMED NAME: KAPLAN GILLA PHD
DATE OF NAME CHANGE: 20030625
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-03
0
0000816284
CELGENE CORP /DE/
CELG
0001247024
KAPLAN GILLA
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
1
0
0
0
Common Stock
2017-03-03
4
M
0
7500
25.575
A
87142
D
Stock Options (Right to Buy)
25.575
2017-03-03
4
M
0
7500
D
2017-03-15
Common Stock
7500
0
D
The option was fully exercisable.
The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan.
/s/ Peter N. Kellogg ___________________________________________________
Peter N. Kellogg, Attorney-in-Fact
2017-03-07